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RENAL TRANSPLANTATION IN CHILDREN WITH 
POSTERIOR URETHRAL VALVES—REVISITED, A 10 YEAR 
FOLLOW-UP
R. Indudhara, M.D., L.M. Pérez, M.D., D.B. Joseph, M.D., 
F.A.A.P., A.G. Diethelm, M.D. University of Alabama at Birming­
ham, Children's Hospital, Birmingham, AL.
Background: Renal transplantation is a safe and effective treat­
ment of end stage renal disease in children w ith posterior urethral 
valves. We have previously reported a 5 year experience showing 
a favorable outcome compared to matched controls. However, 
there was a trend of increased serum creatinine. None of the boys 
had pre-transplant urinary urodynam ic evaluation or bladder re­
construction, we speculated that these boys would suffer progres­
sive renal insufficiency due to unfavorable lower urinary tract 
dynamics. This review was prom pted to determine if our concern 
was substantiated.
Methods: This is a retrospective analysis of clinical case records 
and the computerized transplant data base of 268 children less 
than 19 years of age undergoing renal transplantation between 
May 1968 to November 1988 at our institution. '18 children had the 
sole diagnosis of PUV. These children were matched to a nonob­
structed cohort comparing age, time and num ber of transplants, 
donor type, and immunotherapy. The sam e children used in the 
original 5 year report were reevaluated. All children have at least 
a 10 year follow up  (range: 10-19).
Results; PS = patient survival: GS =  graft survival
Age 5yr PS lOyr PS 5yr GS lOyr GS Creatinine
PUV 9yrs. 94% 94% 69% 54% 2.3mg% 
Control 12yrs. 100% 100% 52% 41% 2.0mg% 
p value 0.06 0.65 0 .9 7  0.37 0.35 0.66
y
Chronic rejection was the leading cause of graft failure in both 
groups (8 & 11 respectively).
Conclusions: O ur ten year follow-up of renal transplantation in 
children with PUV is equal to children w ith renal failure due to 
nonobstructive causes. Five and 10 year graft survival was better 
but not statistically significant in children w ith  PUV. Our concern 
regarding transplanting into a 'valve bladder' was not substanti­
ated. We are continuing w ith pre-transplant urodynamic evalua­
tion and look forward to comparing the outcome in those children 
to this data.
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LONG TERM OUTCOME IN CHILDREN FOLLOWING 
ANTENATAL INTERVENTION FOR OBSTRUCTIVE 
UROPATHY.
Andrew L Freedman, MD, Thom as S Vates, MD, Craig A Smith, 
MD, FAAP, Ricardo Gonzalez, MD, FAAP, M ark I Evans, MD, 
Mark P Johnson, MD. Depts of Urology, Children's Hospital of 
Michigan and Obstetrics and  Gynecology, Hutzel Hospital, 
Wayne State University School of Medicine, Detroit, MI.
Background: The use of fetal intervention for obstructive urop­
athy remains controversial and little is know n regarding the long­
term outcomes of antena tally treated children, In order to better 
define the results of fetal intervention, we reviewed the long-term 
follow-up in children who underw ent vesicoamniotic shunt place­
ment with attention to growth, development, and renal and blad­
der function. METHODS: From a series of 68 patients evaluated 
for presum ed antenatal obstructive uropathy we identified 17 
children who underwent vesicoamniotic shunt placement and are 
survivors greater than two years of age. Follow-up evaluation 
included family interviews and a review of available medical 
records. RESULTS: Of 68 patients evaluated, 23 are alive at greater 
than two years of life of w hom  17 underw ent shunt placement and 
form the basis of this review. The mean age at follow-up was 54.3
months (range 25-114). The diagnosis was prune belly syndrome 
(8), posterior urethral valves (5), urethral atresia (1) and other in 3. 
Recent height was available in 11 children, 5 of whom are below 
the 5th percentile, 4 are between the 10-25th %tile, 1 between 
25-50th %tile and 1 is above the 75th %tile. Of the 13 available 
weights, 4 are below the 5th percentile, 4 are between 5-25th, and
5 between 25-50th percentile. Seven require daily nutritional or 
metabolic supplements. One child has developmental delay and 2 
require speech therapy. The children underwent a total of 58 
operative procedures including 44 major procedures. Three pa­
tients with valves have required bladder augmentation and 4 
children have undergone renal transplantation. Six are fully con­
tinent during the day, one of whom with polyuria has occasional 
wet nights. Toilet training has not yet begun due to parental choice 
in 5 and has failed in one who requires diapers at age 3.5 years. 
The continence status is unknown in 5. Ten children void sponta­
neously per urethra, 3 also perform intermittent catheterization 
due to residual urine and 2 are dependent on catheterization via a 
appendicovesicostomy. No child remains diverted. Nadir serum 
creatinine in the first year of life was available in 15: it was <  0.8 
in 9, between 0.8-1.0 in 2, and >1 in 4. The 4 with nadirs > 1 .0  
have all progressed to renal failure and required renal transplan­
tation. Of the 2 with a nadir creatinine between 0.8-1.0, both have 
developed renal insufficiency with a creatinine clearance <  50 
m l/m in. Of the 9 with nadirs <  0.8; 1 is in renal failure, 1 has renal 
insufficiency and 7 have normal renal function. The majority of 
children with renal impairment had a history of frequent febrile 
urinary infections while most of those with stable renal function 
had few or no infections. CONCLUSIONS: Antenatal intervention 
appears to help children with the most severe forms of obstructive 
uropathy, those usually associated with a fatal outcome, achieve 
long-term results comparable to those diagnosed postnatally. Na­
dir creatinine in the first year of life is a useful predictor of 
long-term renal function. Most children achieve acceptable void­
ing and continence though some with valves may require future 
augmentation. Aggressive treatment of urinary tract dysfunction, 
prevention of infection and early nutritional support plays an 
important role in preserving renal function and ameliorating 
growth deficiency.
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FEASABILITY OF INTRAUTERINE FETAL THERAPY FOR 
OBSTRUCTIVE UROPATHY IN A MONKEY MODEL.
Wouter F. Feitz, MD, FAAP, Eric A. Steegers, MD, Robert P. de 
Gier, MD, Rene G. Aarnink PhD, Bas van der Wildt, MD. Dept 
of Urology, Obstetrics and Gynecology, University Hospital 
Nijmegen, Nijmegen, The Netherlands.
Background: Obstructive uropathy detected by prenatal ultra­
sound investigations has led to conservative as well as invasive, 
treatment strategies. The use of new intervention techniques and 
surgical instruments may decrease the high complication rate and 
offer early treatment possibilities. Methods: In three series of ex­
periments with five rhesus monkeys (Macaca mulatta) each, dif­
ferent endoscopic intra-amnio tic access techniques, morbidity, 
mortality and possibilities for fetoscopy were evaluated. The preg­
nant primates were operated upon at mid trimester (90 to 110 days; 
full term 164 days). Different evaluation methods were used for 
uterine activity and fetal growth during pregnancy. Current avail­
able minimal invasive techniques, instruments and scopes (Karl 
Storz) were used.
Results: In all 15 monkeys, adequate fetoscopy was possible 
with no maternal mortality. Eleven of the 15 pregnancies were 
completed with no early or late complications. Electric uterine 
activity showed no early postoperative contractions in the first 
five animals. Serial ultraound investigations for fetal biometry 
showed no disturbances of the intrauterine growth patterns in one 
group. Technical improvements changed the intrauterine access 
techniques from open placement of trocards to the use of seldinger
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techniques and gun introduction of needles with small caliber 
sheets resulting in lesser amniotic membrane separation. Different 
rigid and flexible scopes could be used for fetoscopy and three
canulas could be placed offering the possibility of intrauterine
i
manipulation.
Conclusion: New techniques have led to the improvement of 
intrauterine fetal access. Morbidity is mainly depending on the 
disruption of amniotic mebranes and plays an important role in 
preterm abortion. New scopes will offer the possibility for fetal 
retrograde cystoscopy for which evaluation this model seems to be 
suitable.
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EXTRAVESICAL REPAIR OF THE OBSTRUCTED 
MEGAURETER DECREASES COST AND POSTOPERATIVE 
PAIN.
John P. Connor, MD, FRSC(C), Claude Reitelman, MD, FAAP, 
M ark Miller, MD, Kevin A, Burbige, MD, FAAP, Dept, of Urol­
ogy, Columbia University, NYC, NY and Michigan Institute of 
Urology, Detroit, ML
Background: The pressure to provide low cost, high quality 
health care has led all surgeons to reevaluate the procedures 
performed. We have found the extravesical approach to anti­
reflux surgery provides excellent results in both cost and efficacy. 
We have since expanded this procedure to include obstructed 
megaureter repairs with significant advantages over intravesical 
techniques. Methods: 44 patients (52 ureters) underw ent extravesi­
cal tapered repairs of obstructed megaureters from 1992 to '1996 at 
our institutions. The patients ranged in age from 1 month to 9 
years. Preoperative evaluation consisted of renal sonography, nu­
clear renography, and voiding cystourethrograms (VCUG). The 
surgical technique consists of the extravesical dissection of the 
megaureter to its stenotic insertion into the bladder. The detrusor 
is divided until the mucosa bulges through, muscle flaps are then 
created. At this point the ureter is dismembered and tapered 
(excisional) over a 10 Fr. catheter. A 5 Fr. ureteral stent is placed 
into the tapered ureter through a tiny bladder incision. The ta­
pered ureter is anastomosed to the distal end of the bladder 
mucosa and the detrusor is then closed over the ureter to create a 
submucosal tunnel. The ureteral stents are removed early on 
postoperative day two and the foley later that day. Results: Mean 
hospital stay was 3.2 days (range 2-5). The last twenty patients 
had a mean hospital stay of 2.8 days. Postoperative anti-cholin­
ergic medication was not required. Postoperative evaluation con­
sisted of a sonogram at 2 weeks, 3,6, and 12 months after surgery 
with a VCUG at 6 months postop. No patient demonstrated reflux 
or persistent obstruction at follow-up. Two patients with bilateral 
repairs had retention lasting five and ten days. Conclusion: Ex­
travesical megaureter repair is a safe, effective procedure with 
significant benefits in both cost and postoperative discomfort over 
intravesical techniques. This procedure also allows for easy iden­
tification of the ureteral blood supply and observation of the 
course of the ureter after repair thus reducing the incidence of 
obstruction and ischemic injury.
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LONG-TERM EFFICACY OF ORAL DESMOPRESSIN 
(DDAVP) IN CHILDREN WITH PRIMARY NOCTURNAL 
ENURESIS (PNE).
Steven J. Slcoog, MD, FAAP. Division of Urology, The Oregon 
Health Sciences U niversity, Portland, O regon, and Arthur 
Stokes, MD and Katherine L. Turner, Rhone-Poulenc Rorer, 
Collegeville, Pennsylvania.
Background: DDAVP nasal spray has proven safety and efficacy 
in the treatment of PNE. Oral DDAVP tablets would provide a 
vehicle more easily used and convenient to the patients and their
parents. This study evaluated the effectiveness of oral DDAVP in 
reducing the number of wet nights in children with PNE over a 
6-month period.
Methods: An open-label, ascending-dose titration, multicenter 
trial of oral DDAVP in children, ages 6-18 years with documented 
PNE was conducted. All children had previously participated in a 
double-blinded, placebo controlled study. Following a 2-week 
. screening period, eligible patients (at least 3 wet nights per week) 
received 200 m eg/day for 2 weeks. The dose was titrated upward 
in increments of 200 meg every 2 weeks until the patient remained 
completely dry over a 2-week period or had reached a maximum 
dose of 600 meg/day. Patients who were not completely dry, but 
had ^  50% reduction in the number of wet nights after 2 weeks on 
600 m eg/ day could continue the study. Any patient who had <  
50% reduction in the number of wet nights could be withdrawn 
from the study at the investigator's discretion. The amount of 
fluids taken with the dose two hours before bedtime was re­
stricted based on body weight. Treatment was continued for up to 
a total of 6 months. The primary efficacy variable was the mean 
reduction from baseline in the number of wet nights during the 
two week treatment period preceding each scheduled clinic visit. 
An excellent response was defined as s  2 wet nights/2 weeks and 
an acceptable response was ^  50% reduction in wet nights.
Results: 231 patients from 29 centers were evaluated; 149 (64%) 
patients completed 6 months of treatment. Eighty-seven percent 
(87%) of the patients were titrated to 600 meg/day. After 2 weeks 
of treatment with 200 meg/day, a 30% mean reduction in wet 
nights was noted. An acceptable response was present in 31% of 
patients. Complete dryness was present in 8% of the children. 
After 6 months of treatment patients receiving the highest 
DDAVP dose showed a mean reduction of 6 wet nights. An 
excellent response was noted in 58 patients (47%), of which 15% 
were completely dry. An acceptable response was seen in 73% of 
patients. Of 20 patients on lower dosage, 95% had an excellent 
response, At all dosages, 19% were completely dry.
Conclusion: Oral DDAVP at daily dosages up to 600 m eg/day 
for 6 months reduced the number of wet nights and was well 
tolerated in patients with PNE. This study was funded by an 
educational grant from Rhone Poulenc Rorer.
PSYCHOSOCIAL IMPACT AND PERCEIVED STRESS OF 
NOCTURNAL ENURESIS
NM van Tijen, AP Messer, Z Namdar (Wilhelmina Children's 
Hospital Utrecht, the Netherlands)
Background: Nocturnal Enuresis (NE) has been highlighted as 
the most prevalent ailment of childhood and from a strictly m ed­
ical point of view considered to be a self-limiting disease, with no 
major health risks. Nevertheless, little research has been devoted 
to the psychosocial impact of NE. The present study focussed 
upon patients' own rating of NE in relation to critical life events 
and its psychosocial implications on social impediment, self­
esteem and coping mechanisms, compared to a reference group.
Methods: 98 NE children (S:6 wet n igh ts/14 days) and 124 
controls (age 8-18 years) entered this questionnaire-based study, 
subdivided into two groups: primary school children (8-12 year; 
mean: 10.2) and adolescents (12-18 year; mean: 13.5). The follow­
ing questionnaires and methods of analysis were used: a, critical 
life event: Critical Life Events Picture Test (CLEFT), specifically 
designed to evaluate the child's impact rating of NE in relation to 
other critical life events, adopted from previous studies. Based on 
five criteria, eleven severe events were selected; divorce, stringent 
parental fights, being teased, being left out of the group, moving, 
undergoing surgery, academic retainment, having little money to 
spend, being extremely short and having to wear glasses. Differ­
ences in perceptions were evaluated by Thurstone's method of 
paired comparison (mean ratings of 'severity of psychological 
impact' (MRS) indicating how often an event is chosen above an
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